COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors

被引:21
|
作者
Chen, Yu-Wei [1 ]
Tucker, Matthew D. [1 ]
Beckermann, Kathryn E. [1 ]
Iams, Wade T. [1 ]
Rini, Brian I. [1 ]
Johnson, Douglas B. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA
关键词
D O I
10.1016/j.ejca.2021.07.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:291 / 293
页数:3
相关论文
共 50 条
  • [41] CARDIAC IMMUNE-RELATED ADVERSE EVENTS IN LUNG CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Kumar, Sany
    Fowler, Cosmo
    Thota, Ajit K.
    Pastores, Stephen M.
    [J]. CHEST, 2023, 164 (04) : 363A - 363A
  • [42] Immune-related Adverse Events in Patients With Cancer Receiving Influenza Vaccination and Immune Checkpoint Inhibitors
    Groeneveld, Geert H.
    Wijn, Dirk H.
    Vollaard, Albert M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1519 - 1519
  • [43] Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
    Simonaggio, Audrey
    Michot, Jean Marie
    Voisin, Anne Laure
    Le Pavec, Jerome
    Collins, Michael
    Lallart, Audrey
    Cengizalp, Geoffray
    Vozy, Aurore
    Laparra, Ariane
    Varga, Andrea
    Hollebecque, Antoine
    Champiat, Stephane
    Marabelle, Aurelien
    Massard, Christophe
    Lambotte, Olivier
    [J]. JAMA ONCOLOGY, 2019, 5 (09) : 1310 - 1317
  • [44] Incidence of immune-related adverse events in US veterans treated with immune checkpoint inhibitors
    Krall, Courtney
    Tague, Marshall
    Lund, Brian C.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [45] Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
    Strobel, Sophia B.
    Machiraju, Devayani
    Kaelber, Katharina A.
    Hassel, Jessica C.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (08) : 2051 - 2056
  • [46] Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
    Sophia B. Strobel
    Devayani Machiraju
    Katharina A. Kälber
    Jessica C. Hassel
    [J]. Cancer Immunology, Immunotherapy, 2022, 71 : 2051 - 2056
  • [47] Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
    Cook, Sarah
    Samuel, Vanessa
    Meyers, Daniel E.
    Stukalin, Igor
    Litt, Ishjot
    Sangha, Randeep
    Morris, Don G.
    Heng, Daniel Y. C.
    Pabani, Aliyah
    Dean, Michelle
    Navani, Vishal
    [J]. JAMA NETWORK OPEN, 2024, 7 (01) : E2352302
  • [48] Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors
    Pan, Catherina X.
    Liu, Mofei
    Lau, Charles B.
    Lau, William C.
    Kim, Daniel Y.
    Saberi, Shahin A.
    Rowley, Rachael
    Kanwar, Ruhi
    Giobbie-Hurder, Anita
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (04) : 826 - 829
  • [49] Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
    Serino, M.
    Freitas, C.
    Martins, M.
    Ferreira, P.
    Cardoso, C.
    Veiga, F.
    Santos, V.
    Araujo, D.
    Novais-Bastos, H.
    Magalhaes, A.
    Queiroga, H.
    Fernandes, G.
    Hespanhol, V.
    [J]. PULMONOLOGY, 2024, 30 (04): : 352 - 361
  • [50] Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors: What Emergency Physicians Need to Know
    Peyrony, O.
    Mathe, S.
    Addou, S.
    Naud, N.
    Madelaine, I.
    Baroudjian, B.
    Lebbe, C.
    Fontaine, J. -P.
    [J]. ANNALES FRANCAISES DE MEDECINE D URGENCE, 2023, 13 (04): : 241 - 253